Noribogaine reduces nicotine self-administration in rats
Noribogaine, a polypharmacological drug with activities at opioid receptors, ionotropic nicotinic receptors, and serotonin reuptake transporters, has been investigated for treatment of substance abuse-related disorders. Smoking cessation has major benefits for both individuals and society, therefore...
| Main Authors: | , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
SAGE Publications
2015
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4456428/ |